David Sans is a Healthcare and Finance leader with significant experience across Pharma and fast-growing Biotech companies:

• EF Hutton appoints David Sans as Head of Healthcare

• Titan Partners Group Announces Addition of Dr. David Sans as Head of Healthcare

• Calidi Biotherapeutics Appoints David Sans, FAARM, Ph.D., MBA, As Head Of Corporate Development

• XORTX Appoints Dr. David Sans in New York as Director Corporate Development

• XORTX Therapeutics Receives Final Approval to List on the TSX Venture Exchange

• Young America Capital Appoints David Sans as MD of Healthcare Investment Banking

• Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participate at the ICDP Summit in Boston